Hilditch et al., 2018 - Google Patents
Does screening for congenital cytomegalovirus at birth improve longer term hearing outcomes?Hilditch et al., 2018
View PDF- Document ID
- 807901224669572767
- Author
- Hilditch C
- Liersch B
- Spurrier N
- Callander E
- Cooper C
- Keir A
- Publication year
- Publication venue
- Archives of Disease in Childhood
External Links
Snippet
Currently, the diagnosis of congenital cytomegalovirus (cCMV) infection in most highly resourced countries is based on clinical suspicion alone. This means only a small proportion of cCMV infections are diagnosed. Identification, through either universal or targeted …
- 241000701022 Cytomegalovirus 0 title description 32
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3493—Computer-assisted epidemiological alert systems, e.g. bioterrorism or flu alerts
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/327—Management of hospital data, e.g. scheduling of medical staff or operation rooms, measuring the quality or efficiency of medical staff
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Puhakka et al. | The burden of congenital cytomegalovirus infection: a prospective cohort study of 20 000 infants in Finland | |
Retzler et al. | Economic cost of congenital CMV in the UK | |
Fowler et al. | A targeted approach for congenital cytomegalovirus screening within newborn hearing screening | |
Hilditch et al. | Does screening for congenital cytomegalovirus at birth improve longer term hearing outcomes? | |
Williams et al. | First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection | |
Beswick et al. | Integration of congenital cytomegalovirus screening within a newborn hearing screening programme | |
Kladny et al. | Genetic counseling following the detection of hemoglobinopathy trait on the newborn screen is well received, improves knowledge, and relieves anxiety | |
Lorenzoni et al. | Neonatal screening for congenital cytomegalovirus infection in preterm and small for gestational age infants | |
Roth et al. | Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening | |
Alcaide et al. | The incidence of Trichomonas vaginalis infection in women attending nine sexually transmitted diseases clinics in the USA | |
Haller et al. | Should hearing targeted screening for congenital cytomegalovirus infection be implemented? | |
Santos-Pinto et al. | Health demands and care of children with congenital Zika syndrome and their mothers in a Brazilian state | |
Gievers et al. | Ethical and public health implications of targeted screening for congenital cytomegalovirus | |
Ross et al. | Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review | |
Perruche et al. | Anxiety and depression are unrecognised in emergency patients admitted to the observation care unit | |
Toumpas et al. | Congenital cytomegalovirus infection is a significant cause of moderate to profound sensorineural hearing loss in Q ueensland children | |
Whaitiri et al. | Genital gonorrhoea in children: determining the source and mode of infection | |
Webb et al. | Feasibility and acceptability of targeted salivary cytomegalovirus screening through universal newborn hearing screening | |
Rohren et al. | Congenital Cytomegalovirus-Associated Sensorineural Hearing Loss in Children: Identification Following Universal Newborn Hearing Screening, Effect of Antiviral Treatment, and Long-Term Hearing Outcomes | |
Tadesse et al. | Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia | |
Zimmerman et al. | Incidence of congenital rubella syndrome at a hospital serving a predominantly Hispanic population, El Paso, Texas | |
Kataoka et al. | Prevalence and risk factors for delayed-onset hearing loss in early childhood: A population-based observational study in Okayama Prefecture, Japan | |
Gaffoor et al. | High risk sexual behaviors are associated with sexual violence among a cohort of women in Durban, South Africa | |
Lodge et al. | Is asthma associated with COVID-19 infection? A UK Biobank analysis | |
Brown et al. | A prospective cohort study characterising the role of anogenital warts in HIV acquisition among men who have sex with men: a study protocol |